Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-22-053884

CFO & Executive Vice President sold 1,629 shares at $40.16 ($65,421)

From the SEC's structured data for this filing

Trades in this filing

Dier Mardi · CFO & Executive Vice President

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-10-14 Sale : show line 1 in the form −1,629 $40.16 $65,421 66,695 D
Open-market sales · 1,629 sh · avg $40.16 · $65,421
Loading xslF345X03/doc4.xml…